Softhale is a medical device startup founded in 2016 with the slogan "Advancing the future of lung drug delivery with innovative Soft Mist Inhalation devices". The company is focused on the development of Soft Mist Inhalation (SMI) devices for the delivery of pharmaceutical drugs to the lungs, operating in the Biotechnology and Health Care industries. Softhale received its Series A investment from New Rhein Healthcare Investors on 30 November 2016. As a company specializing in medical device innovation, Softhale represents a promising investment opportunity in the rapidly evolving healthcare sector with its advanced drug delivery technology.
Softhale
Advancing the future of lung drug delivery with innovative Soft Mist Inhalation devices
Founded 2016
Series A
Biotechnology, Health Care +1
General Information
Get notified when Softhale moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Softhale
Get real-time alerts for funding, hiring, news, and 40+ signal types.
Start Tracking — FreeDiscover More
Biotechnology
About Softhale
Taxonomy: lung drug delivery, medical device company, Soft Mist Inhalation, pharmaceutical drugs, inhalation devices, drug delivery, respiratory medicine, innovation, pulmonary drug delivery, drug administration
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series A | Unknown | 1 |
|
30 Nov 2016 |
Softhale Alternatives & Competitors
Softhale vs
Pioneering advanced respiratory drug delivery solutions for asthma and chronic obstructive pulmonary...
Series D
Biotechnology, Health Care
Softhale vs
Nob Hill Therapeutics
United States
Pioneering Respiratory Patient Care
Series A
4 employees
Biotechnology, Life Sciences
Softhale vs
Kenox Pharmaceuticals, Inc
United States
Pioneering Scientific Solutions for Advancing Human Health
6 employees
Biotechnology, Pharmaceutical
FAQ About Softhale
Advancing the future of lung drug delivery with innovative Soft Mist Inhalation devices
Softhale was founded in 2016.
Softhale operates in the following industries: Biotechnology, Health Care, Medical Devices.
Softhale has completed 1 funding round. The latest funding stage is Series A.
Top alternatives and competitors to Softhale include OMNI, Nob Hill Therapeutics, Kenox Pharmaceuticals, Inc, VERO Biotech, Airway Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Softhale and OMNI are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Don't just browse. Track.
Signal Tracker monitors Softhale and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.